%PDF-1.6
%
1 0 obj
<>stream
VoR
10.1111/1759-7714.12965
10.1111/1759-7714.12965
10.1111/(ISSN)1759-7714
3
application/pdf
The predictive value of skeletal muscle mass for immunotherapy with Nivolumab in NSCLC patients: a "hypothesis-generator" preliminary report.: sarcopenia in NSCLC treated with Nivolumab.
2020-04-02T00:59:40-07:00
2019-01-12T18:50:23+05:30
2020-04-02T00:59:40-07:00
uuid:8f621fff-65bd-4ce7-b5ae-34af9ef38eb3
uuid:7f62f6ec-da05-40e3-83ad-15fbd6de8479
endstream
endobj
4 0 obj
<>stream
HWMoDhl6];^r|8r@rFV~}#GAzU~wi7?^۳rGǿYKȭW۳H4jw~_aLwULA%+o6wGw8Z妩!ƇĴUo+&쪩 #}7p0^ٴW(jOlv_
Ū0UęfLMя@Ig+kN&Kd,u8maw}+-m57ƕ,%mre`ڲ<
3カ?Ng<<ˊc4qĵ"ÖwAfbsdnGa Ns~FF*sЬ '4/u .}vAl ?>M